^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Peritoneal Cancer
    Drug:carboplatin (Alkylating agent) +
    albumin-bound paclitaxel (Tubulin inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Acceptable Recurrence Therapies for…Peritoneal Cancer: Useful in certain circumstances...Carboplatin/Paclitaxel albumin bound